Ann: Imugene EGM Presentation, page-136

  1. 2,846 Posts.
    lightbulb Created with Sketch. 413
    "
    Merck 24th January 2025


    ”We're not planning any transformational deals in pharma," Garijo said, adding that Merck is looking at bolt-on acquisitions of a smaller size and later-stage deals”
    ”we need to remain prudent and patient.

    Aicp ,big pharma are leaning towards later stage trials,as recently stated by Merck , any take over would possibly be many years away , if the data was in fact ,good enough to spark interest.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
26.5¢
Change
-0.010(3.64%)
Mkt cap ! $76.45M
Open High Low Value Volume
27.0¢ 27.5¢ 26.0¢ $429.4K 1.618M

Buyers (Bids)

No. Vol. Price($)
17 433247 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 28052 5
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.